Back to Search
Start Over
Circulating B-type natriuretic peptide in women with and without recent gestational diabetes: The impact of current glucose intolerance
- Source :
- Clinical Endocrinology. 88:227-233
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
-
Abstract
- Context Circulating B-type natriuretic peptide, as measured by the N-terminal fragment of its prohormone (NT-proBNP), is inversely associated with incident type 2 diabetes (T2DM) but positively related to future cardiovascular disease (CVD). Recognizing that gestational diabetes (GDM) identifies women at future risk for both T2DM and CVD, we sought to determine whether gestational glucose tolerance relates to NT-proBNP in the years after delivery. Design/Patients/Measurements Three-hundred-and-forty women underwent a glucose challenge test (GCT) and an oral glucose tolerance test (OGTT) in pregnancy, yielding 4 gestational glucose tolerance groups: GDM (n=105); gestational impaired glucose tolerance (n=59); abnormal GCT with a normal OGTT (n=98); and normal GCT with normal OGTT (n=75). At 3-years postpartum, they underwent cardiometabolic characterization (including measurement of estimated glomerular filtration rate (eGFR), adiponectin, and NT-proBNP) and repeated the OGTT, revealing 69 women with glucose intolerance (pre-diabetes/diabetes). Results At 3-years postpartum, serum NT-proBNP did not differ between the 4 original gestational glucose tolerance groups (p=0.44), but instead progressively decreased across current glucose tolerance strata, from normal to pre-diabetes to diabetes (p=0.006). Indeed, on logistic regression analysis, NT-proBNP emerged as a negative predictor of pre-diabetes/diabetes (OR=0.903, 95%CI 0.825-0.988, p=0.026). On multiple linear regression analyses of NT-proBNP, the significant association with current glucose intolerance was ultimately attenuated in a fully-adjusted model, revealing two independent determinants of NT-proBNP: eGFR (t=-2.71, p=0.007) and adiponectin (t=2.44, p=0.015). Conclusion Serum NT-proBNP relates to current glucose intolerance, rather than preceding gestational dysglycemia. Thus, the diabetic (rather than vascular) risk implications of NT-proBNP predominate in young women. This article is protected by copyright. All rights reserved.
- Subjects :
- Adult
Blood Glucose
medicine.medical_specialty
medicine.drug_class
Endocrinology, Diabetes and Metabolism
030209 endocrinology & metabolism
Context (language use)
Type 2 diabetes
030204 cardiovascular system & hematology
Impaired glucose tolerance
03 medical and health sciences
0302 clinical medicine
Endocrinology
Pregnancy
Internal medicine
Diabetes mellitus
Glucose Intolerance
Natriuretic Peptide, Brain
medicine
Natriuretic peptide
Humans
Prospective Studies
Prediabetes
Adiponectin
business.industry
Postpartum Period
Glucose Tolerance Test
medicine.disease
Peptide Fragments
3. Good health
Gestational diabetes
Diabetes, Gestational
Female
business
hormones, hormone substitutes, and hormone antagonists
Subjects
Details
- ISSN :
- 03000664
- Volume :
- 88
- Database :
- OpenAIRE
- Journal :
- Clinical Endocrinology
- Accession number :
- edsair.doi.dedup.....3bf3e87d6233c9e4c7f9b821c2993609
- Full Text :
- https://doi.org/10.1111/cen.13510